NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹339 Cr | ₹278 Cr | ₹318 Cr | ₹258 Cr | ₹15,168,639 Cr |
What is the latest Revenue of NGL FINECHEM ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹339 Cr |
| Mar2024 | ₹278 Cr |
| Mar2023 | ₹318 Cr |
| Mar2022 | ₹258 Cr |
| Mar2021 | ₹15,168,639 Cr |
How is Revenue of NGL FINECHEM Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹339 Cr | 21.79 | |
| Mar2024 | ₹278 Cr | -12.42 | |
| Mar2023 | ₹318 Cr | 23.08 | |
| Mar2022 | ₹258 Cr | -100.00 | |
| Mar2021 | ₹15,168,639 Cr | - | |
Compare Revenue of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,717.5 Cr | 23.3% | 21.8% | 101.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 23.3% |
21.8% |
101.2% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses